Rocky Shi

758 total citations
11 papers, 323 citations indexed

About

Rocky Shi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rocky Shi has authored 11 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Rocky Shi's work include Pancreatic function and diabetes (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Diabetes and associated disorders (2 papers). Rocky Shi is often cited by papers focused on Pancreatic function and diabetes (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Diabetes and associated disorders (2 papers). Rocky Shi collaborates with scholars based in Canada and United States. Rocky Shi's co-authors include Dan S. Luciani, Ahsen Chaudhry, S. Elizabeth Franks, Kevin L. Bennewith, Rachel A. Cederberg, Fábio Rossi, Melisa J. Hamilton, Momir Bosiljcic, Nancy E. LePard and Bryant Harbourne and has published in prestigious journals such as Nature Communications, Oncogene and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Rocky Shi

10 papers receiving 323 citations

Peers

Rocky Shi
Comparison fields: 5 of 67
  • Molecular Biology 191
  • Immunology 65
  • Oncology 58
  • Cancer Research 40
  • Physiology 32
Replace Maja Sirotković-Skerlev with:
Maja Sirotković-Skerlev Croatia
K Mruk United States
Joël Babdor France
M. Victoria Simón Argentina
Ashley Mackey United States
Dimitrios Strepkos United States
Paola Cuccarolo Italy
Sunny Malhotra Spain
Harutyun Melkonyan Germany
Nagarajan Paramasivam Germany
Maja Sirotković-Skerlev Croatia View profile →
Citations per field, relative to Rocky Shi
Rocky Shi · 1×
Citations per year, relative to Rocky Shi
Rocky Shi · 1×

Countries citing papers authored by Rocky Shi

Since Specialization
Citations

This map shows the geographic impact of Rocky Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocky Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocky Shi more than expected).

Fields of papers citing papers by Rocky Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocky Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocky Shi. The network helps show where Rocky Shi may publish in the future.

Co-authorship network of co-authors of Rocky Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Rocky Shi. A scholar is included among the top collaborators of Rocky Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocky Shi. Rocky Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 0
2 1
3 4
4 3
5 7
6 7
7 20
8 5
9 213
10 62
11 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026